Richardson-based digital health startup Recuro Health had its at-home COVID-19 rapid test platform featured Tuesday at the TOPx Solutions Showcase, presented by the Census Bureau in partnership with the U.S. Department of Health and Human Services (HHS).
The virtual event featured digital solutions from 12 technology teams selected from the HHS COVID-19 At-Anywhere Diagnostics Design-a-thon. Recuro’s platform enables employers to get access to many of the latest FDA Emergency Use Authorization-approved COVID rapid tests.
“After a long year of lockdowns, businesses have suffered deep financial losses and the major push is on to get employees back to work,” said Allison Martin, a founder and executive director of Recuro Health, in a statement. “However, a return to work requires strong assurances of health and safety, which has led to a massive need for affordable, accurate at-home or on-site rapid testing that makes employees feel safe.”
The new startup is led by Founder and CEO Michael Gorton, who previously founded Dallas-based Teladoc and led it as CEO and chairman for its first seven years of operation. Several other leaders with Teladoc experience are now on the Recuro team as well, according to the company.
While at Teladoc, Gorton helped pioneer a new efficiency paradigm in healthcare, connecting physicians to patients nationwide in under 12 minutes for $35.
$2.9 million funding round
Recuro announced March 30th that it had closed its oversubscribed funding round, led by OLSF Ventures, at a reported $2.9 million.
Recuro describes itself as “an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system,” with a goal of offering consumers a “digital medical home.”
Last week Recuro announced it had acquired SupDoc, an AI-enabled telehealth startup with a holistic, cost-effective model for care delivery. Recuro says SupDoc will enhance its virtual health platform, “a curated suite of telehealth solutions that enables consumers to engage with physicians, receive personalized care and monitor their own health, no matter their location or circumstance.”
“This acquisition allows us to seamlessly leverage additional capabilities to meet an individual’s healthcare needs,” Gorton said in a statement. “By enabling earlier interventions and more personalized care, our patient-centric digital medical home delivers better outcomes at a lower cost, benefiting consumers, providers, payers and employers.”
Recuro’s digital health model takes an integrated care team approach, addressing primary care and behavioral health issues with a unified group of primary care physicians, psychiatrists, and counselors, the company said in the statement. Its model also offers consumers tools to monitor and support their health, from home testing to screening capabilities to genetic testing.
Note: This story was updated to reflect that Recuro did not develop a test; it developed a platform that enables employers to get access to many of the latest FDA EUA-approved COVID-19 rapid tests. Updated May 28, 2021, at 5:02 pm.